Emergent Biosolutions Snags Upgrade After FDA Approves OTC Narcan

The biotech plans to launch the over-the-counter product this summer, beating competitors to the punch.

Related Keywords

Robert Wasserman ,Drug Administration ,Emergent Biosolutions ,Biotechnology Services ,Pharmaceuticals ,Over The Counter Drugs ,Banking ,Savings Institutions ,Healthcare Life Sciences ,Biopharmaceuticals ,Banking Credit ,Financial Services ,Regulation Government Policy ,Analysts 39 Comments Recommendations ,New Products Services ,Product Service Approvals ,Corporate Industrial News ,Products Services ,Drug Substance Use Abuse ,Political General News ,Society Community ,Heroin Illegal Opioid Use Abuse ,Social Issues ,Content Types ,Factiva Filters ,C Ampe Exclusion Filter ,C Ampe Industry News Filter ,Synd ,Biotech And Pharma ,Companies ,Webs ,Bavarian Nordic ,Bava Ko ,Dk Bava ,S Ampp 500 Index ,Spx ,Dow Jones Industrial Average ,Djia ,Regulation ,Government Policy ,Analysts 39 Comments ,Recommendations ,New Products ,Services ,Product ,Service Approvals ,Corporate ,Industrial News ,Products ,Drug ,Substance Use ,Abuse ,Political ,General News ,Society ,Community ,Heroin ,Illegal Opioid Use ,Healthcare ,Life Sciences ,Credit ,